Dr Jui Vyas

2022

• Vyas, J., Muirhead, N., Singh, R., Ephgrave, R. and Finlay, A. Y. 2022. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open 12(5), article number: e058128. (10.1136/bmjopen-2021-058128)

2021

• Brittain, E., Muirhead, N., Finlay, A. Y. and Vyas, J. 2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): major impact on lives of both patients and family members. Medicina 57(1), article number: 43. (10.3390/medicina57010043)
• Akingbola, C. O. and Vyas, J. 2021. Dermatological history and examination. Medicine 49(6), pp. 343-349. (10.1016/j.mpmed.2021.03.002)

2020

• Altayeb, A., Cordaro, A., Caesar, J., Vyas, J. and Ingram, J. 2020. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms. International Journal of Dermatology 59(12), pp. 1541-1542. (10.1111/ijd.15247)
• Kwan, K. and Vyas, J. 2020. A retrospective audit to assess the safety and efficacy of apremilast use in chronic plaque psoriasis. Future Healthcare Journal 7(Suppl), pp. s47-s48. (10.7861/fhj.7.1.s47)
• Ali, F., Vyas, J. and Finlay, A. Y. 2020. Counting the burden: atopic dermatitis and health-related quality of life. Acta Dermato-Venereologica 100(12), article number: adv00161. (10.2340/00015555-3511)

2019

• Luke, K., Kiss, F. and Vyas, J. 2019. Authentic assessments: building interactive learning objects. Presented at: Cardiff University Learning & Teaching Conference 2019: Authentic Learning, Cardiff, Wales, UK, 11 Sept 2019. pp. -.

2017

• Akingbola, C. O. and Vyas, J. 2017. Traction alopecia: a neglected entity in 2017. Indian Journal of Dermatology, Venereology, and Leprology 83(6), pp. 644-649. (10.4103/ijdvl.IJDVL_553_16)
• Ali, F., Cueva, A., Vyas, J., Atwan, A., Salek, M., Finlay, A. and Piguet, V. 2017. A systematic review of the use of quality-of-life instruments in randomised controlled trials of psoriasis. British Journal of Dermatology 176(3), pp. 577-593. (10.1111/bjd.14788)
• Salek, S., Ali, F., Cueva, A., Vyas, J., Piguet, V. and Finlay, A. 2017. The value of quality of life assessment in monitoring the efficacy of interventions in psoriasis and the role of minimal clinically important difference in interpretation of scores: a systematic review. International Journal of Clinical Pharmacy 39(1), pp. 238., article number: PE007. (10.1007/s11096-016-0404-4)

2016

• Ali, F. M., Cueva, A. C., Atwan, A. A., Vyas, J., Piguet, V., Salek, S. and Finlay, A. Y. 2016. Systematic review: do treatments for psoriasis meet the minimal clinically important difference for PRO measures?. Quality of Life Research 25(S1), pp. 70-71., article number: 1004. (10.1007/s11136-016-1390-7)
• Ali, F. M., Cueva, A., Vyas, J., Atwan, A. A., Piguet, V., Salek, S. and Finlay, A. 2016. The impact of interventions on quality of life in psoriasis and the concept of multiple minimal clinically important difference (MCID): a systematic review. Journal of Investigative Dermatology 136(9:S2), pp. S166., article number: 31. (10.1016/j.jid.2016.06.048)
• Ali, F., Cueva, A., Vyas, J., Piguet, V., Salek, S. and Finlay, A. 2016. A systematic review of the impact on quality of life of interventions for psoriasis. British Journal of Dermatology 175(S1), pp. 54., article number: P64. (10.1111/bjd.14524)
• Ali, F., Cueva, A., Atwan, A., Vyas, J., Piguet, V., Finlay, A. and Salek, S. 2016. Can systematic reviews help with choosing a suitable health-related quality of life measure in interventional studies of psoriasis?. International Journal of Clinical Pharmacy 38(2), pp. 565-565., article number: PE012. (10.1007/s11096-015-0240-y)